462
Participants
Start Date
June 1, 2024
Primary Completion Date
August 30, 2027
Study Completion Date
November 30, 2027
Intra-arterial tenecteplase injection at the completion of thrombectomy
Intra-arterial tenecteplase (0.062mg/kg, maximum 6.25mg) administered as a bolus at the completion of thrombectomy through a microcatheter at the site of the initial-but-now-retrieved intracranial occlusion, or in direct contact with the residual thrombus
Placebo
intra-arterial bolus of 0.9% Sodium Chloride solution
RECRUITING
Gold Coast Univeristy Hospital, Gold Coast
RECRUITING
Royal Adelaide Hospital, Adelaide
NOT_YET_RECRUITING
Princess Alexandra Hospital, Brisbane
NOT_YET_RECRUITING
Royal Brisbane and Women's Hospital, Brisbane
NOT_YET_RECRUITING
Canberra Hospital, Canberra
RECRUITING
Alfred Hospital, Melbourne
RECRUITING
Austin Hospital, Melbourne
NOT_YET_RECRUITING
Monash Medical Centre, Melbourne
RECRUITING
Royal Melbourne Hospital, Melbourne
NOT_YET_RECRUITING
John Hunter Hospital, Newcastle
NOT_YET_RECRUITING
Fiona Stanley Hospital, Perth
NOT_YET_RECRUITING
Liverpool Hospital, Sydney
NOT_YET_RECRUITING
Royal North Shore Hospital, Sydney
University of Melbourne
OTHER